News and Events
Study uncovers mechanism behind effectiveness of three-drug combination in patients with a rare bile duct cancer
Combining anti-VEGF therapy with immune checkpoint inhibitors stimulated the production of B cells to fight cholangiocarcinoma, a rare bile duct cancer.
Read More